CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 588 enrolled
Drug / intervention
Comparator: etoricoxib +3 moredrug
Likely dose
Comparator: etoricoxib 90 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00694369
NCT00694369Phase 3Completed
CompareCT.gov

A Phase III Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled Multiple-Dose Clinical Trial to Study the Efficacy and Safety of MK0663/Etoricoxib 90 and 120 mg, Ibuprofen 600 mg, and Acetaminophen 600 mg/Codeine 60 mg in the Treatment of Patients With Postoperative Dental Pain

Organon and Co·interventional·Posted Jun 10, 2008·Updated Feb 9, 2022

In Brief

A Phase 3 clinical trial evaluating Comparator: etoricoxib, Comparator: ibuprofen, and 2 other interventions for Postoperative Dental Pain. Completed, enrolled 588 participants.

Detailed Summary

The purpose of this study is to compare the pain relieving effect of different doses of MK0663 with placebo and other pain relievers/analgesics in patients with postoperative dental pain. Pain intensity and relief will be measured by the total pain relief score (TOPAR) and patient evaluation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostoperative Dental Pain
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 10, 2008
Enrollment StartJun 1, 2008
Primary CompletionDec 1, 2008
Study CompletionJan 1, 2009
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 18.1 years ago

Interventions

Comparator: etoricoxibdrug

etoricoxib 90 mg; 120 mg (once daily) over three days.

Comparator: ibuprofendrug

ibuprofen 2400 mg (600 mg Q6h) over three Days

Comparator: acetaminophen + codeinedrug

acetaminophen 2400 mg/codeine 240 mg (600/60 mg Q6h) over three Days

Comparator: placebodrug

matching placebo over three Days